Coalition for Aligning Science

Coalition for Aligning Science

An implementation-focused philanthropic organization that manages and seeds large-scale, collaborative neuroscience initiatives to accelerate treatments for central nervous system disorders. [31mzda] [e5udwu] [hgy2k4]
The Coalition for Aligning Science (CAS) is a nonprofit implementation partner and managing entity behind multi-stakeholder neuroscience efforts, most prominently Aligning Science Across Parkinson’s (ASAP) and the broader CNS Quest initiative. [31mzda] [e5udwu] [hgy2k4] CAS focuses on designing and running open-science research programs and investment vehicles that target central nervous system (CNS) disorders such as Parkinson’s disease, autism, and bipolar disorder. [31mzda] It operates primarily from the United States, working globally through academic, philanthropic, and industry partners. [31mzda] [jf1cpb] [v25aga] Consultants track CAS because it is a central orchestrator and funder of large, collaborative, data-sharing neuroscience programs that shape the Parkinson’s and CNS research landscape. [e5udwu] [jf1cpb] [v25aga] [hgy2k4]

Identity and Form

  • Type: This organization is a nonprofit that manages and implements large-scale neuroscience research and innovation initiatives. [31mzda] [e5udwu] [jf1cpb] [v25aga] [hgy2k4]
  • Legal form and jurisdiction: • Operates as a nonprofit initiative manager based in the United States; ASAP is described as “managed by the Coalition for Aligning Science (CAS),” indicating CAS functions as the managing organization rather than a commercial subsidiary. [e5udwu] [jf1cpb] [v25aga]
  • Headquarters and presence: • Headquartered in the United States (ASAP communications list Washington, D.C. as the base city for major announcements) with a global program footprint through international research networks and partnerships. [jf1cpb] [v25aga]
  • Size: • No reliable public headcount or staffing figures for CAS itself were found; public materials focus on networked investigators and teams rather than CAS employees. [e5udwu] [jf1cpb] [v25aga]
  • Where it lives online: • Homepage: AligningScience.com (Coalition for Aligning Science site hosting initiatives like CNS Quest and ASAP). [31mzda] [hgy2k4] • ASAP program site: ParkinsonsRoadmap.org (Aligning Science Across Parkinson’s, described as “a program of the Aligning Science Across Parkinson’s initiative… managed by the Coalition for Aligning Science”). [e5udwu] [v25aga] • Collaborative Research Network info: ASAP CRN “About” page describing the CRN and explicitly crediting CAS as manager. [e5udwu]

Mission and Identity

  • Stated mission: > “The Quest is focused on accelerating discoveries, advancing treatments and care, and improving the daily lives of people impacted by Parkinson’s disease, autism, bipolar disorder, and other central nervous system conditions—shortening the journey from lab to living well.” [31mzda]
CAS positions itself as the implementation backbone for philanthropic and investment initiatives that accelerate CNS research, engineer collaboration, and drive open science and policy change rather than acting as a traditional grant-making foundation. [31mzda] [e5udwu] [hgy2k4] Through CNS Quest and ASAP, it emphasizes serving people living with Parkinson’s and other CNS conditions by building collaborative research networks, shared data resources, and funding structures that close gaps between discovery and patient impact. [31mzda] [e5udwu] [jf1cpb] [v25aga] [hgy2k4] CAS foregrounds themes of flexible capital, open data and rapid learning, and risk-tolerant, systems-level interventions in neuroscience innovation ecosystems. [31mzda] [e5udwu]
  • Stated values / operating principles: CNS Quest (run under CAS) highlights three core approach pillars: “Leverage flexible capital,” “Engineer collaboration,” and “Take bold risks,” describing use of philanthropy and strategic investments, open-science programs and communities of practice, and policy change to remove barriers to innovation and access. [31mzda]

What They Do

CAS designs and manages multi-year, multi-stakeholder neuroscience programs that combine philanthropic grants, strategic investments, and policy and infrastructure work to speed development of treatments and tools for CNS disorders. [31mzda] [e5udwu] [jf1cpb] [v25aga] [hgy2k4] Day to day, this includes running competitive research funding cycles, standing up collaborative research networks, creating shared research resources, coordinating with implementation partners like The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and aligning funders and investigators around open-science practices. [e5udwu] [jf1cpb] [v25aga] [hgy2k4] CAS generates impact by channeling capital and coordination capacity into high-leverage neuroscience initiatives rather than selling products or services. [31mzda] [e5udwu] [jf1cpb] [v25aga]
Main initiatives and activities:
  • CNS Quest — A broader initiative “focused on accelerating discoveries, advancing treatments and care, and improving the daily lives of people impacted by Parkinson’s disease, autism, bipolar disorder, and other central nervous system conditions,” funded by philanthropic and investment capital from the Sergey Brin Family Foundation and Catalyst4. [31mzda]
  • Aligning Science Across Parkinson’s (ASAP) — A flagship initiative “fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease,” managed by CAS and implemented in partnership with MJFF. [e5udwu] [jf1cpb] [v25aga] [hgy2k4]
  • Collaborative Research Network (CRN) — A “program of the Aligning Science Across Parkinson’s initiative” that “foster[s] an environment that facilitates the rapid and free exchange of scientific ideas to spark new discoveries for Parkinson’s disease (PD),” designed and managed under ASAP/CAS. [e5udwu] [jf1cpb]
  • Research funding and grant-making — Through ASAP, CAS administers large-scale grants; in April 2026 ASAP (managed by CAS) announced $261 million in new grant funding for the CRN, with each team receiving $6–9 million over three years depending on theme. [jf1cpb] [v25aga]
  • Open science research programs and data-sharing infrastructure — CAS, via CNS Quest and ASAP, “create[s] open science research programs and communities of practice to share data, learn rapidly, and apply insights,” including building standardized toolkits and global research resources for Parkinson’s. [31mzda] [e5udwu] [jf1cpb] [v25aga]
  • Strategic investments in companies — CNS Quest “funds scientific research and invests in companies as part of its efforts to accelerate pathways to treatments and cures and improve lives of those impacted by central nervous system conditions.” [31mzda]
  • Policy and ecosystem change — CNS Quest describes a commitment to “drive policy change to dismantle barriers to innovation and access,” signaling CAS’s role in advocacy and ecosystem-level interventions around CNS research and care. [31mzda]
  • Implementation partnerships — ASAP “partners with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to implement its programs,” with CAS as the managing entity coordinating across funders, MJFF, and research institutions. [jf1cpb] [v25aga]

Leadership and People

No authoritative public sources identified specific named executives, board members, or founders of the Coalition for Aligning Science; available materials attribute roles at the initiative level (e.g., ASAP program leads) but do not clearly map them to CAS governance. [e5udwu] [jf1cpb] [v25aga] [hgy2k4]

History and Origin Story

Public information frames CAS through the evolution of ASAP and CNS Quest rather than as a stand-alone brand, but the origin story centers on major philanthropic backers seeking to reshape Parkinson’s and CNS research through coordinated, open-science initiatives. [31mzda] [e5udwu] [jf1cpb] [v25aga] [hgy2k4] Aligning Science Across Parkinson’s (ASAP) emerged as a large-scale initiative to understand the causes of Parkinson’s disease and was set up with the Coalition for Aligning Science as its managing organization, partnering with MJFF for program implementation and leveraging substantial philanthropic capital from the Sergey Brin Family Foundation and others. [31mzda] [jf1cpb] [v25aga] [hgy2k4] CNS Quest subsequently broadened the scope beyond Parkinson’s to a wider set of CNS conditions, again positioned as part of a “broader initiative” in which CAS plays an implementation and coordination role. [31mzda]
Key inflection points:
  • 2019–2020 (inferred window, based on CRN framing) — ASAP establishes its Collaborative Research Network (CRN) as “the first of its kind to foster an environment that facilitates the rapid and free exchange of scientific ideas” for Parkinson’s disease, under management by CAS. [e5udwu]
  • By the time of CNS Quest launch (date not explicitly stated) — CAS and its funders create CNS Quest, described as “part of a broader initiative” to address Parkinson’s, autism, bipolar disorder, and other CNS conditions using flexible capital, open science, and policy change. [31mzda]
  • April 28, 2026 — Aligning Science Across Parkinson’s (ASAP), “managed by the Coalition for Aligning Science (CAS)” and partnering with MJFF, announces $261 million in new grant funding to expand the CRN toward personalized treatments, marking a major scaling of the program. [jf1cpb] [v25aga]

Financials and Funding

CAS functions as a program and initiative manager; public disclosures focus on initiative-level grant budgets rather than CAS’s own organizational financials. [31mzda] [jf1cpb] [v25aga] [hgy2k4]
  • Funding model: CAS is funded through philanthropic and investment capital from entities such as the Sergey Brin Family Foundation and Catalyst4, which back CNS Quest and related programs, and through programmatic partnerships with organizations like MJFF. [31mzda] [jf1cpb] [v25aga]
  • Major program budgets: In 2026, ASAP (managed by CAS) and MJFF committed $261 million in new grant funding for the CRN’s next phase, with individual teams receiving $6–9 million over three years. [jf1cpb] [v25aga]
No separate 990 filings, endowment figures, or CAS-level financial statements were identified in search results; public-facing numbers are reported at the initiative/grant level rather than for CAS as an entity. [31mzda] [jf1cpb] [v25aga] [hgy2k4]

Milestones and Signature Output

  • Aligning Science Across Parkinson’s (ASAP) creation and CRN launch — Year not explicitly stated, but ASAP’s CRN is described as a novel, large-scale Parkinson’s research network “foster[ing]… rapid and free exchange of scientific ideas,” positioning CAS as manager of a major open-science consortium. [e5udwu]
  • Establishment of CNS Quest — CNS Quest is introduced as “part of a broader initiative” focused on CNS conditions beyond Parkinson’s, with a defined approach of flexible capital, engineered collaboration, and bold risk-taking, funded by the Sergey Brin Family Foundation and Catalyst4. [31mzda]
  • ASAP–MJFF implementation partnership — ASAP “partners with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to implement its programs,” cementing CAS’s role at the center of a leading global Parkinson’s research collaboration. [jf1cpb] [v25aga]
  • Build-out of global research resources and toolkits — Through the CRN, ASAP (managed by CAS) commits to “build a standardized toolkit of global research resources that are needed to turn discoveries into treatments” for Parkinson’s, making shared data and tools a signature output. [jf1cpb] [v25aga]
  • 2026 CRN expansion with $261M — On April 28, 2026, ASAP and MJFF announce $261 million in new CRN grants to “map the biological blueprint of Parkinson’s disease” and advance personalized treatments, with CAS as managing organization. [jf1cpb] [v25aga]

Ecosystem and Relationships

  • Aligning Science Across Parkinson’s (ASAP) — A major program “managed by the Coalition for Aligning Science (CAS),” through which much of CAS’s Parkinson’s-focused work is structured. [e5udwu] [jf1cpb] [v25aga] [hgy2k4]
  • The Michael J. Fox Foundation for Parkinson’s Research (MJFF) — Implementation partner; ASAP “partners with [MJFF] to implement its programs,” working alongside CAS. [jf1cpb] [v25aga]
  • Sergey Brin Family Foundation — Philanthropic funder; CNS Quest is “funded by philanthropic and investment capital from the Sergey Brin Family Foundation and Catalyst4.” [31mzda]
  • Catalyst4 — Investment and philanthropic partner co-funding CNS Quest alongside the Sergey Brin Family Foundation. [31mzda]
  • CNS Quest — Broader CNS initiative in which CAS is an “implementation partner,” focusing on Parkinson’s disease, autism, bipolar disorder, and other CNS conditions. [31mzda]
  • ASAP Collaborative Research Network (CRN) institutions — Numerous universities and research organizations participate in the CRN, which is “a program of the Aligning Science Across Parkinson’s initiative” managed by CAS; these institutions form CAS’s extended scientific ecosystem. [e5udwu] [jf1cpb]

Recent Developments

As of 2026-05-25,
  • 2026-04-28 — $261M CRN expansion — Aligning Science Across Parkinson’s (ASAP), “managed by the Coalition for Aligning Science (CAS),” and MJFF announce $261 million in new grant funding for the Collaborative Research Network to map the biological blueprint of Parkinson’s and build standardized global research toolkits. [jf1cpb] [v25aga]
  • 2026-04-28 — Shift toward personalized treatments — The same announcement frames the new CRN funding round as an investment “toward personalized treatments,” with each team receiving $6–9 million over three years, signaling CAS’s role in steering the network toward precision medicine for Parkinson’s. [jf1cpb] [v25aga]
No other CAS-specific developments within the last ~90 days surfaced beyond the April 2026 ASAP/MJFF funding announcement, which dominates current coverage. [jf1cpb] [v25aga]

Impact

  • Impact on society
    • Through ASAP’s CRN, managed by CAS, hundreds of scientists globally are organized into teams aiming to “map the biological blueprint of Parkinson’s disease” and develop resources needed to translate discoveries into treatments, potentially impacting millions of people living with Parkinson’s worldwide. [e5udwu] [jf1cpb] [v25aga]
    • CNS Quest’s remit across Parkinson’s, autism, bipolar disorder, and other CNS conditions positions CAS-backed programs to improve “the daily lives of people impacted” by these disorders by shortening the path “from lab to living well.” [31mzda]
  • Impact on innovation
    • CAS, via ASAP’s CRN, advances open-science, collaboration-first research models in Parkinson’s, explicitly emphasizing “rapid and free exchange of scientific ideas” and shared toolkits, which contrasts with more siloed traditional grant structures. [e5udwu] [jf1cpb]
    • By combining philanthropy and strategic investments and “taking bold risks” on ideas others “can’t or won’t” fund, CNS Quest under CAS encourages higher-risk, translational CNS projects that might otherwise struggle for support. [31mzda]
  • Impact on its industry or domain
    • CAS-managed ASAP and the CRN have become reference points in Parkinson’s research funding; the 2026 $261M expansion represents one of the largest coordinated grant packages in the field, likely prompting other funders and consortia to consider similar large-scale, networked approaches. [jf1cpb] [v25aga]
    • The focus on building standardized, global research resources (toolkits, data) for Parkinson’s sets expectations for infrastructure-building as a core component of modern disease-specific philanthropy and research strategy. [jf1cpb] [v25aga]
  • Historical significance
    • While relatively young, the combination of CAS’s management role, ASAP’s global CRN, and the scale of recent funding commitments positions the Coalition for Aligning Science as a key architect in the emerging history of open, networked Parkinson’s and CNS research. [e5udwu] [jf1cpb] [v25aga]
  • Criticisms and controversies
    • No substantive independent criticisms, controversies, or regulatory findings specifically targeting the Coalition for Aligning Science were identified in available search results; coverage is predominantly descriptive and focused on program launches and funding announcements. [31mzda] [e5udwu] [jf1cpb] [v25aga] [hgy2k4]

Adjacent Entries

  • The Michael J. Fox Foundation for Parkinson’s Research — Major implementation partner for ASAP programs managed by CAS. [jf1cpb] [v25aga]
  • Aligning Science Across Parkinson’s (ASAP) — Flagship Parkinson’s initiative managed by CAS. [e5udwu] [jf1cpb] [v25aga] [hgy2k4]
  • Sergey Brin Family Foundation — Key philanthropic funder backing CNS Quest. [31mzda]
  • Catalyst4 — Investment/philanthropic partner co-funding CNS Quest. [31mzda]
  • Open Science Research Consortia — CAS’s CRN model exemplifies open, collaborative, data-sharing consortia in disease research. [e5udwu] [jf1cpb]
  • Neurodegenerative Disease Research Funding Models — CAS-managed initiatives are a case study in large-scale, networked funding for Parkinson’s and other CNS conditions. [31mzda] [e5udwu] [jf1cpb] [v25aga]

Sources